Cardiovascular Magnetic Resonance Assessment of Ischemic and Nonischemic Cardiomyopathies

Heart Failure Clinics

Volumn 2, Issue 2, 2006, Pages 145-161

  Raney, Aidan R ^a   Bello, David ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOIDOSIS; CARDIOLOGY; CARDIOMYOPATHY; CHAGAS DISEASE; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY DISEASE; DISEASE CLASSIFICATION; FABRY DISEASE; HEART DISEASE; HEART RIGHT VENTRICLE DYSPLASIA; HEMOCHROMATOSIS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INFILTRATIVE CARDIOMYOPATHY; ISCHEMIC HEART DISEASE; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; RESTRICTIVE CARDIOMYOPATHY; REVIEW; SARCOIDOSIS; WORLD HEALTH ORGANIZATION;

AMYLOIDOSIS; CARDIOMYOPATHIES; CARDIOMYOPATHY, HYPERTROPHIC; CARDIOMYOPATHY, RESTRICTIVE; CHAGAS CARDIOMYOPATHY; FABRY DISEASE; HEMOCHROMATOSIS; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDIAL ISCHEMIA; MYOCARDITIS; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY;

EID: 33744754750     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2006.01.001     Document Type: Review

References (71)

1. Richardson P., McKenna W., Bristow M., et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 93 5 (1996) 841-842
2. American Heart Association. Heart disease and stroke statistics: 2005 update (2005), American Heart Association, Dallas (TX)
3. Koelling T.M., Chen R.S., Lubwama R.N., et al. The expanding national burden of heart failure in the United States: the influence of heart failure in women. Am Heart J 147 1 (2004) 74-78
4. Hunt S.A., Abraham W.T., Chin S.H., et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult-summary article A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 46 6 (2005) 1116-1143
5. Doherty III N.E., Fujita N., Caputo G.R., et al. Measurement of right ventricular mass in normal and dilated cardiomyopathic ventricles using cine magnetic resonance imaging. Am J Cardiol 69 14 (1992) 1223-1228
6. Semelka R.C., Tomei E., Wagner S., et al. Interstudy reproducibility of dimensional and functional measurements between cine magnetic resonance studies in the morphologically abnormal left ventricle. Am Heart J 119 6 (1990) 1367-1373
7. Bellenger N.G., Davies L.C., Francis J.M., et al. Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2 4 (2000) 271-278
8. Simonetti O.P., Kim R.J., Fieno D.S., et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 218 1 (2001) 215-223
9. Rehwald W.G., Fieno D.S., Chen E.L., et al. Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation 105 2 (2002) 224-229
10. Kim R.J., Wu E., Rafael A., et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343 20 (2000) 1445-1453
11. Bello D., Shah D.J., Farah G.M., et al. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation 108 16 (2003) 1945-1953
12. Mahrholdt H., Wagner A., Judd R.M., et al. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 26 15 (2005) 1461-1474
13. McCrohon J.A., Moon J.C., Prasad S.K., et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 108 1 (2003) 54-59
14. Soriano C.J., Ridocci F., Estornell J., et al. Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance. J Am Coll Cardiol 45 5 (2005) 743-748
15. Wu E., Judd R.M., Vargas J.D., et al. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 357 9249 (2001) 21-28
16. Kaushal R.E.A., Fieno D., Radin M., et al. Detection of myocardial infarction in patients with ischemic, nonischemic and mixed cardiomyopathy by contrast-enhanced MRI. J Cardiovasc Magn Reson 7 1 (2005) 241
17. Schuster E.H., and Bulkley B.H. Ischemic cardiomyopathy: a clinicopathologic study of fourteen patients. Am Heart J 100 (1980) 506-512
18. Uretsky B.F., Thygesen K., Armstrong P.W., et al. Acute coronary findings at autopsy in heart failure patients with sudden cardiac death: results from the Assessment of Treatment with Lisinopril and Survival (ATLAS) trial. Circulation 102 (2000) 611-616
19. Topol E.J., and Yadav J.S. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 101 5 (2000) 570-580
20. Arroyo L.H., and Lee R.T. Mechanisms of plaque rupture: mechanical and biologic interactions. Cardiovasc Res 41 2 (1999) 369-375
21. Roberts W.C., Siefel R.J., and McManus B.M. Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients. Am J Cardiol 60 (1987) 1340-1355
22. Kim R.J., and Judd R.M. Gadolinium-enhanced magnetic resonance imaging in hypertrophic cardiomyopathy: in vivo imaging of the pathologic substrate for premature cardiac death?. J Am Coll Cardiol 41 9 (2003) 1568-1572
23. Posma J.L., Blanksma P.K., van der Wall E.E., et al. Assessment of quantitative hypertrophy scores in hypertrophic cardiomyopathy: magnetic resonance imaging versus echocardiography. Am Heart J 132 5 (1996) 1020-1027
24. Soler R., Rodriguez E., Rodriguez J.A., et al. Magnetic resonance imaging of apical hypertrophic cardiomyopathy. J Thorac Imaging 12 3 (1997) 221-225
25. Devlin A.M., Moore N.R., and Ostman-Smith I. A comparison of MRI and echocardiography in hypertrophic cardiomyopathy. Br J Radiol 72 855 (1999) 258-264
26. Moon J.C., Fisher N.G., McKenna W.J., et al. Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart 90 6 (2004) 645-649
27. Pons-Llado G., Carreras F., Borras X., et al. Comparison of morphologic assessment of hypertrophic cardiomyopathy by magnetic resonance versus echocardiographic imaging. Am J Cardiol 79 12 (1997) 1651-1656
28. Suzuki J., Watanabe F., Takenaka K., et al. New subtype of apical hypertrophic cardiomyopathy identified with nuclear magnetic resonance imaging as an underlying cause of markedly inverted T waves. J Am Coll Cardiol 22 4 (1993) 1175-1181
29. Arrive L., Assayag P., Russ G., et al. MRI and cine MRI of asymmetric septal hypertrophic cardiomyopathy. J Comput Assist Tomogr 18 3 (1994) 376-382
30. Sato T., Yamanari H., Ohe T., et al. Regional left ventricular contractile dynamics in hypertrophic cardiomyopathy evaluated by magnetic resonance imaging. Heart Vessels 11 5 (1996) 248-254
31. Kramer C.M., Reichek N., Ferrari V.A., et al. Regional heterogeneity of function in hypertrophic cardiomyopathy. Circulation 90 1 (1994) 186-194
32. Schwammenthal E., Wichter T., Joachimsen K., et al. Detection of regional left ventricular asynchrony in obstructive hypertrophic cardiomyopathy by magnetic resonance imaging. Am Heart J 127 3 (1994) 600-606
33. Teraoka K., Hirano M., Ookubo H., et al. Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy. Magn Reson Imaging 22 2 (2004) 155-161
34. Bogaert J., Goldstein M., Tannouri F., et al. Original report. Late myocardial enhancement in hypertrophic cardiomyopathy with contrast-enhanced MR imaging. AJR Am J Roentgenol 180 4 (2003) 981-985
35. Choudhury L., Mahrholdt H., Wagner A., et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 40 12 (2002) 2156-2164
36. Amano Y., Takayama M., Takahama K., et al. Delayed hyper-enhancement of myocardium in hypertrophic cardiomyopathy with asymmetrical septal hypertrophy: comparison with global and regional cardiac MR imaging appearances. J Magn Reson Imaging 20 4 (2004) 595-600
37. Kuribayashi T., and Roberts W.C. Myocardial disarray at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy. Am J Cardiol 70 15 (1992) 1333-1340
38. Moon J.C., Mogensen J., Elliott P.M., et al. Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I. Heart 91 8 (2005) 1036-1040
39. Moon J.C., McKenna W.J., McCrohon J.A., et al. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 41 9 (2003) 1561-1567
40. Amano Y., Takayama M., Amano M., et al. MRI of cardiac morphology and function after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy. AJR Am J Roentgenol 182 2 (2004) 523-527
41. Gertz M.A., and Rajkumar S.V. Primary systemic amyloidosis. Curr Treat Options Oncol 3 3 (2002) 261-271
42. Hamer J.P., Janssen S., van Rijswijk M.H., et al. Amyloid cardiomyopathy in systemic non-hereditary amyloidosis: clinical, echocardiographic and electrocardiographic findings in 30 patients with AA and 24 patients with AL amyloidosis. Eur Heart J 13 5 (1992) 623-627
43. Celletti F., Fattori R., Napoli G., et al. Assessment of restrictive cardiomyopathy of amyloid or idiopathic etiology by magnetic resonance imaging. Am J Cardiol 83 5 (1999) 798-801
44. Maceira A.M., Joshi J., Prasad S.K., et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 111 2 (2005) 186-193
45. Fattori R., Rocchi G., Celletti F., et al. Contribution of magnetic resonance imaging in the differential diagnosis of cardiac amyloidosis and symmetric hypertrophic cardiomyopathy. Am Heart J 136 5 (1998) 824-830
46. Perugini E., Rapezzi C., Piva T., et al. Noninvasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. Heart (2005) [in press]
47. Silverman K.J., Hutchins G.M., and Bulkley B.H. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 58 6 (1978) 1204-1211
48. Yazaki Y., Isobe M., Hiramitsu S., et al. Comparison of clinical features and prognosis of cardiac sarcoidosis and idiopathic dilated cardiomyopathy. Am J Cardiol 82 4 (1998) 537-540
49. Yazaki Y., Isobe M., Hiroe M., et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 88 9 (2001) 1006-1010
50. Smedema J.P., Snoep G., van Kroonenburgh M.P., et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 45 10 (2005) 1683-1690
51. Uemura A., Morimoto S., Hiramitsu S., et al. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J 138 2 Pt 1 (1999) 299-302
52. Vignaux O. Cardiac sarcoidosis: spectrum of MRI features. AJR Am J Roentgenol 184 1 (2005) 249-254
53. Tadamura E., Yamamuro M., Kubo S., et al. Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging. AJR Am J Roentgenol 185 1 (2005) 110-115
54. Vignaux O., Dhote R., Duboc D., et al. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study. Chest 122 6 (2002) 1895-1901
55. Ooi G.C., Chen F.E., Chan K.N., et al. Qualitative and quantitative magnetic resonance imaging in haemoglobin H disease: screening for iron overload. Clin Radiol 54 2 (1999) 98-102
56. Anderson L.J., Holden S., Davis B., et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 22 23 (2001) 2171-2179
57. Siegelman E.S., Mitchell D.G., and Semelka R.C. Abdominal iron deposition: metabolism, MR findings, and clinical importance. Radiology 199 1 (1996) 13-22
58. Kremastinos D.T., Tsiapras D.P., Tsetsos G.A., et al. Left ventricular diastolic Doppler characteristics in beta-thalassemia major. Circulation 88 3 (1993) 1127-1135
59. Anderson L.J., Westwood M.A., Holden S., et al. Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance. Br J Haematol 127 3 (2004) 348-355
60. Fontaine G., Fontaliran F., and Frank R. Arrhythmogenic right ventricular cardiomyopathies: clinical forms and main differential diagnoses. Circulation 97 16 (1998) 1532-1535
61. Gemayel C., Pelliccia A., and Thompson P.D. Arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol 38 7 (2001) 1773-1781
62. Kayser H.W., van der Wall E.E., Sivananthan M.U., et al. Diagnosis of arrhythmogenic right ventricular dysplasia: a review. Radiographics 22 3 (2002) 639-650 [discussion 649-50]
63. Burke A.P., Farb A., Tashko G., et al. Arrhythmogenic right ventricular cardiomyopathy and fatty replacement of the right ventricular myocardium: are they different diseases?. Circulation 97 16 (1998) 1571-1580
64. Bomma C., Dalal D., Tandri H., et al. Regional differences in systolic and diastolic function in arrhythmogenic right ventricular dysplasia/cardiomyopathy using magnetic resonance imaging. Am J Cardiol 95 12 (2005) 1507-1511
65. Tandri H., Saranathan M., Rodriguez E.R., et al. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol 45 1 (2005) 98-103
66. Angelini A., AngBasso C., Nava A., et al. Endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy. Am Heart J 132 1 Pt 1 (1996) 203-206
67. Laissy J.P., Hyafil F., Feldman L.J., et al. Differentiating acute myocardial infarction from myocarditis: diagnostic value of early- and delayed-perfusion cardiac MR imaging. Radiology 237 1 (2005) 75-82
68. Rochitte C.E., Oliveira P.F., Andrade J.M., et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of disease severity. J Am Coll Cardiol 46 8 (2005) 1553-1558
69. Moon J.C., Sachdev B., Elkington A.G., et al. Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease: evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J 24 23 (2003) 2151-2155
70. Bello D. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol 45 7 (2005) 1104-1108
71. Bello D., Fieno D., Kim R., et al. Cardiac MRI: infarct size is an independent predictor of mortality in patients with coronary artery disease. J Am Coll Cardiol 45 3 (2005) 288A